Manufacturing, Aseptic Processing

Oct 01, 2018
BioPharm International
This article explores the use of single-use mixing technology in a detergent-based virus inactivation step during a monoclonal antibody production process.
Sep 27, 2018
By BioPharm International Editors
The sterile-manufacturing contract development manufacturing organization is approved by FDA for viral vector manufacturing fill/finish processing at its biologics facility in Scotland, UK.
Sep 06, 2018
By BioPharm International Editors
The company is increasing manufacturing capacity at its Copenhagen, Denmark facility with the addition of six new bioreactors.
Sep 01, 2018
BioPharm International
The US Pharmacopeial Convention (USP) is developing a new chapter for rapid sterility testing of short-life products based on the recommendations of a panel of experts and stakeholders.
Sep 01, 2018
BioPharm International
Viral vaccines and viral vectors used in biotherapeutic applications carry the risk of microbial contamination, which must be addressed.
Sep 01, 2018
BioPharm International
Automation can improve many aspects of bioprocessing, but several hurdles must be overcome before the full range of benefits can be realized.
Sep 01, 2018
BioPharm International
By BioPharm International Editors
Watson-Marlow Fluid Technology Group added a new actuator suitable for applications where reduced weight is a concern.
Jul 27, 2018
By BioPharm International Editors
Pfizer will invest nearly half a billion dollars to build a sterile injectable facility in Michigan.
Jun 15, 2018
BioPharm International
Single-use technologies have become increasingly prevalent in final fill/finish operations for biologics.
Jun 15, 2018
BioPharm International
Understanding differences in bioreactor lifecycle, design space, and product platforms is important for selecting a bioreactor type.
native1_300x100
lorem ipsum